ARCHIVES

Interim Funding: Noncompeting Renewals Reduced By 4 Percent, Competing Current Plus 7 Percent

This article is from The Cancer Letter archive.

Vol. 08 No. 02 | January 8, 1982

Download PDF Visit The Full Archive

Related Articles

FDA Announces Plan to Reform Drug Approval, Hire Outside Experts To Handel Some Reviews

November 22, 1991

NIH Alternative Medicine Office Releases RFA For Grant Awards

April 9, 1993

Gene Therapy Experiments Get RDAC Okay

August 10, 1990

NCAB Approves Concept Of Four Contract Program

May 29, 1981

NCI Director John Niederhuber Favors Hands-On Management, Revives Institute’s Former Organizational Structure, Abandons Senior Management Team to Work Closely With Deputies and Division Directors.

September 22, 2006

Hearing Scheduled To Investigate ImClone’s C225 Development, Stock Trading

June 7, 2002